Sun Pharma’s Asthma and COPD Inhaler Among Finalists for 2012 MDEA Awards

Combitide Starhaler, a dry powder inhaler for asthma and chronic obstructive pulmonary disease patients, is one of the finalists of the 2012 Medical Design Excellence (MDEA) awards. The inhaler, manufactured by Sun Pharma Advanced Research Company Ltd (Mumbai), is nominated in the General Hospital Devices and Therapeutic Products category.

The annual MDEA awards ceremony is organised by UBM Canon and sponsored by MD+DI. It recognises achievements of medical product manufacturers and the people behind the scenes—engineers, scientists, designers and clinicians. The event will be held during the MD&M East tradeshow on 23 May at the Marriott hotel in Philadelphia. Up to one Bronze, Silver and Gold winner will be announced in each category.

The Combitide Starhaler entry was submitted by Cambridge Consultants (Cambridge, UK). Design Directions (Pune), Sun Pharma Advanced Research Co. Ltd (Vadodara), Foboha GmbH (Haslach, Germany) and Nypro Forbes Pvt. Ltd (Hosur) were recognised for supply/design of the product.

The full list of MDEA finalists are available in MD+DI’s 2012 MDEA finalists slideshow.

—Camilla Andersson

Tags: Combitide Starhaler, MD&M East, MD+DI, MDEA, Medical Design Excellence Awards, Sun Pharmaceutical Industries